The Combating Illicit Xylazine Act places xylazine - a veterinary sedative increasingly found in illicit drug mixtures - into Schedule III of the Controlled Substances Act, subjecting it to federal regulation as a controlled substance. It specifically allows veterinary use without requiring registration of the ultimate user (e.g., pet owners or veterinarians) if xylazine is dispensed by a registered veterinarian or pharmacy with a vet prescription and used for animals owned by the user, under their care, or in authorized animal programs. The bill provides a one-year delay for labeling and packaging requirements and a 60-day delay for registration and recordkeeping for veterinary use to ease implementation. Additionally, it adds xylazine to the Arcos tracking system for controlled substances and mandates two congressional reports on illicit use prevalence within 18 months and 4 years of enactment.
The DPA Modernization Act of 2026 updates the Defense Production Act of 1950 to strengthen national defense manufacturing and supply chain resilience. It creates a Defense Production Act Committee with specific roles, establishes a Defense Production Act Fund with a new Fund manager, and adds new provisions for critical minerals resilience. The bill increases funding limits for certain programs (e.g., raising caps from $10,000 to $100,000) and requires new reporting requirements to improve transparency. It also creates a Defense Production Act Dashboard for tracking activities and adds fraud risk management requirements. The bill affects Federal agencies that use the Defense Production Act authorities to support national defense manufacturing and supply chains.
This bill expands the U.S. Secret Service's authority to investigate money laundering and cybercrime by explicitly adding these offenses to their existing mandate. It extends the period for sharing financial data with law enforcement from 5 to 10 years under FinCEN rules and increases reporting requirements for international financial institutions from 6 to 10 years. The bill also requires the Government Accountability Office to report on law enforcement's ability to identify and stop money laundering in cybercrime within one year of enactment. These changes directly affect federal law enforcement agencies, financial institutions, and cybersecurity investigators by strengthening investigative tools and data access.
This Senate resolution formally recognizes March as Deep Vein Thrombosis and Pulmonary Embolism Awareness Month to highlight these serious health conditions. The bill does not create new laws or funding but serves as a symbolic gesture to encourage public awareness and education about blood clot risks. It affects the general public by promoting information about prevention, symptoms, and the importance of early detection for these life-threatening conditions. The resolution underscores that approximately 900,000 people in the United States are affected annually and that many deaths from these conditions are preventable.
This resolution requires Members of Congress who must reimburse the Treasury for payments related to sexual harassment or discrimination claims to publicly disclose the details of those reimbursements in the House chamber. It mandates that the Office of Congressional Workplace Rights report these cases to the Clerk, who will then read the Member's name, the reimbursement amount, and related information aloud during a House session. Members who fail to comply within 30 days face restrictions on committee assignments and leadership duties, while former Members are barred from entering the House building until they complete reimbursement and undergo the public disclosure process. The measure also establishes that failures to comply with these requirements can be investigated separately by the House Ethics Committee.
The Small Business Innovation and Economic Security Act amends the SBIR and STTR programs to enhance security reviews of small business concerns receiving federal research funding. It requires agencies to assess security risks related to foreign entities by checking against specific government lists, including those related to Chinese military-industrial complex companies. The bill creates a new "strategic breakthrough" funding mechanism for high-potential small businesses with specific requirements like prior awards and matching funds. It also reduces administrative burdens by setting limits on the number of proposals small businesses can submit and improves data collection about program awards. The bill extends the SBIR and STTR programs through fiscal year 2031.
Holocaust Expropriated Art Recovery Act of 2025 This act permanently extends and expands judicial authority under the Holocaust Expropriated Art Recovery Act of 2016. The law allows and establishes procedures for civil claims and causes of action to recover artwork and other property lost between 1933 and 1945 because of Nazi persecution. Among the changes, the act removes the deadline for filing civil claims or causes of action. Currently, the filing deadline is December 31, 2026. (Claims must still be filed within six years of the claimant's discovery of the property in question.) The act permits courts to exercise jurisdiction over civil claims or causes of action against a foreign state without regard to the nationality or citizenship of the alleged victim. The art or property at issue must still have a connection to the foreign state's commercial activities in the United States. Additionally, the act authorizes nationwide service of process, which allows courts to exercise personal jurisdiction over defendants in any judicial district where they may be found, reside, have an agent, or transact business. Finally, the act limits the defenses that may be asserted against civil claims or causes of action, including by prohibiting defenses based on the passage of time, including equitable defenses such as laches (i.e., unreasonable delays); and discretionary bases for dismissal that are unrelated to the merits of the claim, including international comity (i.e., deference to the laws of other countries). These changes apply to pending and future civil claims or causes of action.
This bill requires the VA and Defense Department to assess how well their current mental health programs help servicemembers and veterans transition to civilian life. Specifically, it mandates the Joint Executive Committee to complete an inventory of existing mental health services across the transition process and report findings - including any gaps or inefficiencies - to Congress within 180 days. It also directs the Committee to review the joint separation health assessment tool biennially to ensure its questions remain relevant and effective. The bill directly affects the VA and Defense Department agencies responsible for veterans' mental health care, aiming to improve coordination without creating new benefits or services.
The Strengthen Taxpayer Rights Act of 2026 limits which IRS employees can participate in appeals conferences without taxpayer permission. Specifically, it prohibits IRS staff from attending these conferences unless the taxpayer explicitly agrees to their presence. This change directly affects individuals requesting appeals through the IRS Independent Office of Appeals. The provision aims to give taxpayers more control over who represents the government during their appeal hearings. It applies to all conferences held after the law is enacted.
This bill creates two new tax incentives to encourage the production and investment in renewable materials derived from biomass. The first provision offers a production credit of 10 cents per pound for qualified renewable materials sold or used in business, while the second provides an investment credit equal to 30 percent of qualified property costs used in renewable material facilities. Both credits are limited to facilities located in the United States or its possessions and exclude products intended for fuel, heat, electricity, food, or feed. The bill also allows these tax credits to be transferred to other taxpayers and requires the Treasury Department to issue implementing regulations within 180 days of enactment.
This bill requires Medicare Part D prescription drug plans to include certain lower-cost generic drugs and biosimilar biological products in preferred positions on their formularies starting in 2027. It mandates that these lower-cost alternatives be placed on more favorable tiers with reduced out-of-pocket costs compared to their brand-name counterparts. Additionally, the legislation prohibits plans from imposing stricter access restrictions, such as prior authorization or step therapy, on these lower-cost options than those applied to the original brand-name drugs. The measure directly affects Medicare beneficiaries enrolled in Part D plans and the insurance sponsors who manage those formularies.
This bill amends federal child pornography laws to strengthen protections against the sexual exploitation of minors. It requires that laws against importing or depicting children in sexually explicit material apply even when the child did not participate in the conduct, as long as the person intentionally included the child in the image. The changes update legal definitions to ensure that individuals who knowingly place minors in explicit visual depictions face criminal penalties regardless of the minor's actual involvement. These provisions directly affect law enforcement, prosecutors, and individuals involved in the production or distribution of such material. The bill focuses on closing legal gaps in how child exploitation cases are defined and prosecuted under existing federal statutes.
